利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN109381465A 沃诺拉赞在制备抗痛风制剂中的应用 无效 - 驳回

沃诺拉赞在制备抗痛风制剂中的应用
摘要：
本发明公开了游离形式或药学上可接受的盐形式的沃诺拉赞用于制备抗痛风制剂的用途。有益效果为：游离形式或药学上可接受的盐形式的沃诺拉赞能够抑制黄嘌呤氧化酶的活性，阻止次黄嘌呤和黄嘌呤代谢为尿酸，从而减少了尿酸的生成，能够有效预防由高尿酸血症引起的痛风症状。
摘要（英）：

The present invention discloses the use of vorolazan in a free form or a pharmaceutically acceptable salt form for preparation of an anti-gout formulation. The beneficial effects are: vorolazan in free form or pharmaceutically acceptable salt form can inhibit the activity of xanthine oxidase, and prevent the metabolism of hypoxanthine and xanthine into uric acid, thereby reducing the production ofuric acid, and effectively preventing gout symptoms caused by hyperudricemia.

0/0